XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.2
SHAREHOLDERS' EQUITY (Tables)
9 Months Ended
May 31, 2024
Equity [Abstract]  
Schedule of Shares Outstanding
Shares Outstanding

Shares of Company's common stock outstanding for the three and nine months ended May 31, 2024, and May 31, 2023, were as follows:
Three Months EndedNine Months Ended
(in thousands)May 31, 2024May 31, 2023May 31, 2024May 31, 2023
Common stock outstanding, beginning of period19,984 19,931 19,938 20,260 
Common stock repurchased during the period— (83)— (492)
Common stock issued during the period23 80 69 159 
Common stock outstanding, end of period20,007 19,927 20,007 19,927 
Schedule of Dividends Payable
The Company’s Board of Directors declared cash dividends during the nine months ended May 31, 2024 and fiscal year ended August 31, 2023. The details of dividends paid are in the following tables:
(in thousands, except dividend per share)Nine Months Ended May 31, 2024
Record DateDistribution DateNumber of Shares
Outstanding on
Record Date
Dividend per
Share
Total Amount
10/30/202311/06/202319,939 $0.06 $1,196 
1/29/20242/05/202419,973 $0.06 1,198 
4/29/20245/06/202419,998 $0.06 1,200 
Total$3,594 
(in thousands, except dividend per share) Fiscal Year Ended August 31, 2023
Record DateDistribution DateNumber of Shares
Outstanding on
Record Date
Dividend per
Share
Total Amount
10/31/202211/07/202220,299 $0.06 $1,218 
1/30/20232/06/202319,924 $0.06 1,195 
4/24/20235/01/202319,999 $0.06 1,200 
7/31/20238/07/202319,931 $0.06 1,196 
Total  $4,809 
Share-based Payment Arrangement, Option, Activity
The following table summarizes information about stock options:
(in thousands, except per share and weighted-average amounts)
Activity for the nine months ended May 31, 2024Number of
Options
Weighted-Average
Exercise Price
Per Share
Weighted-Average
Remaining
Contractual Life
Outstanding, August 31, 20231,478 $34.62 6.62 years
Granted566 40.42 
Exercised(73)15.25 
Canceled/Forfeited(13)45.36 
Outstanding, May 31, 20241,958 $36.95 7.01 years
Vested and Exercisable, May 31, 2024851 $29.78 4.81 years
Vested and Expected to Vest, May 31, 20241,886 $36.80 6.92 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the nine-month period ended May 31, 2024 and for the fiscal year ended August 31, 2023:
(in thousands, except weighted-average amounts)Nine Months Ended May 31, 2024Fiscal Year 2023
Estimated fair value of awards granted$11,229 $10,067 
Unvested Forfeiture Rate5.80 %0.22 %
Weighted-average grant price$40.42 $43.78 
Weighted-average market price$40.42 $43.78 
Weighted-average volatility44.47 %46.14 %
Weighted-average risk-free rate4.79 %4.29 %
Weighted-average dividend yield0.59 %0.55 %
Weighted-average expected life6.59 years6.55 years
Share-based Payment Arrangement, Option, Exercise Price Range
The exercise prices for the options outstanding at May 31, 2024, ranged from $6.85 to $66.14 per share, and the information relating to these options are as follows:
(in thousands except prices and weighted-average amounts)
Exercise Price Per ShareAwards OutstandingAwards Exercisable
LowHighQuantityWeighted -Average
Remaining
Contractual
Life
Weighted-Average
Exercise
Price
QuantityWeighted-Average
Remaining
Contractual
Life
Weighted-Average
Exercise
Price
$6.85 $9.77 165 1.38 years$9.02 164 1.38 years$9.02 
$9.78 $18.76 145 2.74 years$10.08 145 2.74 years$10.08 
$18.77 $33.40 179 4.91 years$25.73 162 4.84 years$24.98 
$33.41 $47.63 1,199 8.65 years$41.35 212 7.45 years$41.06 
$47.64 $66.14 270 6.81 years$56.33 168 6.61 years$57.54 
  1,958 7.01 years$36.95 851 4.81 years$29.78